Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters

ANTONIO RIVERO ROMÁN2026-01-292026-01-29202410.1016/j.ijantimicag.2023.1070162-s2.0-85179089291https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/37206Infectious DiseasesMicrobiology (medical)Pharmacology (medical)Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presentersresearch article